Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This letter discusses the emerging use of Janus kinase inhibitors, specifically oral tofacitinib, for treating alopecia areata in children, but reports no new clinical findings.

This review discusses topical and intralesional treatments for alopecia areata, providing a management strategy based on patient age and disease severity, but reports no new clinical results.

This study found that patients with alopecia areata exhibit a stronger deficiency in coping with stress compared to those with androgenetic alopecia and controls, suggesting a psychosomatic component to the condition.

In this retrospective study, anti-tuberculous agents, likely rifampicin, were effective adjunctive therapies for a chalazion, coinciding with spontaneous drainage in a patient with rosacea.

This article reviews the relationship between hair loss and lithium but does not provide any new clinical findings.

This paper contains author contact information and disclosures without reporting new research findings or results.

This paper explores the social challenges individuals with medical hair loss face when using wigs, highlighting the complex identity management involved and the social obligations to disclose wig use to close ones.

The laser comb did not improve hair regrowth in mice with alopecia areata.

This article discusses alopecia areata, highlighting its autoimmune nature and the lack of FDA-approved treatments, without providing new research findings.

This study found that thymus transplantation in athymic mice resulted in T-cell-driven hair follicle depigmentation and loss, without multiorgan autoimmune disease, highlighting mechanisms of tissue-specific tolerance.

This study found that alopecia areata presents diverse hair loss patterns and a range of treatment options, though no treatment was universally effective, and significantly impacts patients' psychological well-being.

This review evaluates laser therapy for alopecia areata, noting that fractional lasers facilitate hair growth and drug delivery, but reports no new clinical results.

This case report details a 46-year-old woman with severe atopic dermatitis and alopecia areata universalis who experienced renewed hair growth and improved skin symptoms after starting dupilumab therapy.

This review discusses emerging evidence on azathioprine's efficacy and safety for severe alopecia areata, reporting sustained response in many patients but emphasizing the need for controlled trials.

This research focuses on alopecia areata, highlighting the psychological impact, especially of its variant alopecia areata incognita, and provides diagnostic and treatment tips, but does not report specific results.

This article discusses Janus kinase inhibitors as a promising future treatment for alopecia areata but does not present new research findings.

COVID-19 vaccination may be linked to alopecia areata, especially in young adults.

This review discusses the promising role of JAK inhibitors in managing alopecia areata, reporting significant hair regrowth and acceptable safety profiles but noting the need for further research on dosing and long-term safety.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

This study found that prolonged tofacitinib treatment in adult Indian patients with moderate-to-severe alopecia areata was associated with a high regrowth rate, which varied with factors like age at disease onset and treatment duration.

This study found that yellow dots seen under dermatoscopy are a sensitive and specific indicator of treatment response in alopecia areata, showing significant reduction as early as four weeks.

This review examines the clinical presentation and management strategies for alopecia areata, focusing on pediatric patients, and highlights the need for addressing its psychological impacts; it reports no new clinical findings.

This review examines current treatment options for alopecia areata and highlights the challenges due to limited evidence-based data and unpredictability in disease progression.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Azathioprine may be an effective treatment for severe hair loss.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

This article discusses various forms of hair loss and their psychological impacts, noting the lack of definitive treatments, but reports no new clinical findings.

In this case report, a middle-aged male with Grade V androgenetic alopecia saw sustained improvement in hair loss and quality of life after individualized homeopathic treatment at Dr Batra’s Homeopathy Clinic, despite previous therapies failing to provide long-term satisfaction.